InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（4 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
4
T+90 胜率
0%
T+90 平均收益
-33.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Duhay Francis, 董事. Insider active across 2 companies, notably Hancock Jaffe Laboratories, Inc.. In total, 7 disclosures have been logged. Breakdown: 3 buys · 4 sells. Total volume traded: €335k. History available since 17 May 2021. The latest transaction was filed on 11 September 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Duhay Francis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
11 股@ US$11.21Common StockSEC:0001493152-26-042629:0
140 股@ US$11.52240.5% 占其流量Common StockSEC:0001493152-26-010047:0
4,900 股@ US$0.35560.5% 占其流量Common StockSEC:0001493152-25-027510:0
4,900 股@ US$0.831.2% 占其流量Common StockSEC:0001493152-25-013837:0
81,433 股@ US$3.0783.7% 占其流量Common StockSEC:0001493152-25-000160:0
标准退出：2025年3月31日 (T+90)
7,751 股@ US$6.1416.3% 占其流量Common StockSEC:0001493152-22-023461:0
标准退出：2022年11月14日 (T+90)
9,492 股@ US$5.33100.0% 占其流量Common Stock, $$0.00001 par valueSEC:0001493152-21-012296:0
标准退出：2021年8月15日 (T+90)
7 条申报中的 7 条
About Duhay Francis
Duhay Francis is Administrateur at enVVeno Medical Corp and Hancock Jaffe Laboratories, Inc. Across 6 filings in total, the 6 sampled filings run from 2021-05-19 to 2026-03-13, with EUR 328651 in buys and EUR 6344 in sells, and the modal transaction nature is Cession.
